Cargando…

An Overview of Molecular Mechanisms in Fabry Disease

Fabry disease (FD) (OMIM #301500) is a rare genetic lysosomal storage disorder (LSD). LSDs are characterized by inappropriate lipid accumulation in lysosomes due to specific enzyme deficiencies. In FD, the defective enzyme is α-galactosidase A (α-Gal A), which is due to a mutation in the GLA gene on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amodio, Federica, Caiazza, Martina, Monda, Emanuele, Rubino, Marta, Capodicasa, Laura, Chiosi, Flavia, Simonelli, Vincenzo, Dongiglio, Francesca, Fimiani, Fabio, Pepe, Nicola, Chimenti, Cristina, Calabrò, Paolo, Limongelli, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599883/ https://www.ncbi.nlm.nih.gov/pubmed/36291669 http://dx.doi.org/10.3390/biom12101460

Ejemplares similares

Pathophysiology, Functional Assessment and Prognostic Implications of Nutritional Disorders in Systemic Amyloidosis
por: Dongiglio, Francesca, et al.
Publicado: (2023)

Cardiovascular Involvement in Fabry’s Disease: New Advances in Diagnostic Strategies, Outcome Prediction and Management
por: Monda, Emanuele, et al.
Publicado: (2023)

Molecular Basis of Inflammation in the Pathogenesis of Cardiomyopathies
por: Monda, Emanuele, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy in Children: Pathophysiology, Diagnosis, and Treatment of Non-sarcomeric Causes
por: Monda, Emanuele, et al.
Publicado: (2021)

Aortopathies in mouse models of Pompe, Fabry and Mucopolysaccharidosis IIIB lysosomal storage diseases
por: Belfiore, Maria Paola, et al.
Publicado: (2020)

The Role of Genetic Testing in Patients with Heritable Thoracic Aortic Diseases
por: Monda, Emanuele, et al.
Publicado: (2023)

Troponin T Mutation as a Cause of Left Ventricular Systolic Dysfunction in a Young Patient with Previous Surgical Correction of Aortic Coarctation
por: Caiazza, Martina, et al.
Publicado: (2021)

Thoracic Aortic Dilation: Implications for Physical Activity and Sport Participation
por: Monda, Emanuele, et al.
Publicado: (2022)

Multimodality Imaging in Arrhythmogenic Left Ventricular Cardiomyopathy
por: Monda, Emanuele, et al.
Publicado: (2023)

The Biological Role of Vitamins in Athletes’ Muscle, Heart and Microbiota
por: Brancaccio, Mariarita, et al.
Publicado: (2022)

Multidisciplinary In-Depth Investigation in a Young Athlete Suffering from Syncope Caused by Myocardial Bridge
por: Brancaccio, Mariarita, et al.
Publicado: (2021)

Global Left Ventricular Myocardial Work Efficiency in Heart Failure Patients with Cardiac Amyloidosis: Pathophysiological Implications and Role in Differential Diagnosis
por: Palmiero, Giuseppe, et al.
Publicado: (2021)

Exercise, Immune System, Nutrition, Respiratory and Cardiovascular Diseases during COVID-19: A Complex Combination
por: Scudiero, Olga, et al.
Publicado: (2021)

Clinical, Genetic, and Histological Characterization of Patients with Rare Neuromuscular and Mitochondrial Diseases Presenting with Different Cardiomyopathy Phenotypes
por: Monda, Emanuele, et al.
Publicado: (2023)

Combined PTPN11 and MYBPC3 Gene Mutations in an Adult Patient with Noonan Syndrome and Hypertrophic Cardiomyopathy
por: Caiazza, Martina, et al.
Publicado: (2020)

Dietary Thiols: A Potential Supporting Strategy against Oxidative Stress in Heart Failure and Muscular Damage during Sports Activity
por: Brancaccio, Mariarita, et al.
Publicado: (2020)

Genetic analysis resolves differential diagnosis of a familial syndromic dilated cardiomyopathy: A new case of Alström syndrome
por: Lombardo, Barbara, et al.
Publicado: (2020)

Impact of Regular Physical Activity on Aortic Diameter Progression in Paediatric Patients with Bicuspid Aortic Valve
por: Monda, Emanuele, et al.
Publicado: (2021)

Imaging the “Hot Phase” of a Familiar Left-Dominant Arrhythmogenic Cardiomyopathy
por: Rubino, Marta, et al.
Publicado: (2021)

A pilot clinical trial with losartan in Myhre syndrome
por: Cappuccio, Gerarda, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy—Current Challenges and Future Perspectives
por: Monda, Emanuele, et al.
Publicado: (2023)

Multimodality Imaging in Cardiomyopathies with Hypertrophic Phenotypes
por: Monda, Emanuele, et al.
Publicado: (2022)

Immune‐Mediated Myocarditis in Fabry Disease Cardiomyopathy
por: Frustaci, Andrea, et al.
Publicado: (2018)

Editorial: Paediatric Cardiomyopathies
por: Monda, Emanuele, et al.
Publicado: (2021)

Editorial: Cardiovascular genetics—focus on paediatric cardiomyopathy
por: Monda, Emanuele, et al.
Publicado: (2023)

Next-Generation Sequencing Gene Panels in Inheritable Cardiomyopathies and Channelopathies: Prevalence of Pathogenic Variants and Variants of Unknown Significance in Uncommon Genes
por: Mazzaccara, Cristina, et al.
Publicado: (2022)

Diagnostic Clues for the Diagnosis of Nonsarcomeric Hypertrophic Cardiomyopathy (Phenocopies): Amyloidosis, Fabry Disease, and Mitochondrial Disease
por: Limongelli, Giuseppe, et al.
Publicado: (2018)

The Role of von Willebrand Factor in Vascular Inflammation: From Pathogenesis to Targeted Therapy
por: Gragnano, Felice, et al.
Publicado: (2017)

Role of Handheld In Vivo Reflectance Confocal Microscopy for the Diagnosis of Fabry Disease: A Case Report
por: Cinotti, Elisa, et al.
Publicado: (2018)

Hypertrophy of unaffected cardiomyocytes correlates with severity of cardiomyopathy in female patients with Fabry disease
por: Chimenti, Cristina, et al.
Publicado: (2021)

Effect of a Fixed Combination of Curcumin, Artemisia, Bromelain, and Black Pepper Oral Administration on Optical Coherence Tomography Angiography Indices in Patients with Diabetic Macular Edema
por: Chiosi, Flavia, et al.
Publicado: (2022)

The Hidden Fragility in the Heart of the Athletes: A Review of Genetic Biomarkers
por: Barretta, Ferdinando, et al.
Publicado: (2020)

Cardiac and skeletal myopathy in Fabry disease: a clinicopathologic correlative study()()
por: Chimenti, Cristina, et al.
Publicado: (2012)

A Novel Homozygous GPAA1 Variant in a Patient with a Glycosylphosphatidylinositol Biosynthesis Defect
por: Fontana, Paolo, et al.
Publicado: (2023)

Cardiac magnetic resonance in Fabry disease
por: Lanzillo, Chiara, et al.
Publicado: (2023)

Fabry Disease: More than a Phenocopy of Hypertrophic Cardiomyopathy
por: Stankowski, Kamil, et al.
Publicado: (2023)

Severe Lymphatic Disorder and Multifocal Atrial Tachycardia Treated with Trametinib in a Patient with Noonan Syndrome and SOS1 Mutation
por: Lioncino, Michele, et al.
Publicado: (2022)

Complete atrioventricular canal
por: Calabrò, Raffaele, et al.
Publicado: (2006)

Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease?
por: Duro, Giovanni, et al.
Publicado: (2018)

Cardiac abnormalities in Anderson-Fabry disease and Fabry’s cardiomyopathy
por: Morrissey, Ryan P, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_od68ftg306g9smckp1etp1vkl0